✦ LIBER ✦

Cisplatin and treosulfane chemotherapy in the treatment of metastatic ovarian cancer

✍ Scribed by Bähr, I.; Merkle, E.; Henke, A.; Bühner, M.; Lang, N.

Book ID: 123006621
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 148 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91348-O

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin and treosulfane chemotherapy i

Cisplatin and treosulfane chemotherapy in the treatment of metastatic ovarian cancer

✍ Bähr, I.; Merkle, E.; Henke, A.; Bühner, M.; Lang, N. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Cisplatin and treosulfane chemotherapy i

Cisplatin and treosulfane chemotherapy in the treatment of metastatic ovarian cancer — low versus high dose

✍ Merkle, E.; Bähr, I.; Henke, A.; Bühner, M.; Lang, N. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Cisplatin and treosulfane chemotherapy i

Cisplatin and treosulfane chemotherapy in the treatment of metastatic ovarian cancer -low versus high dose

✍ Merkle, E.; Bähr, I.; Henke, A.; Bühner, M.; Lang, N. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

540 - Adjuvant cisplatin and treosulfan

540 - Adjuvant cisplatin and treosulfan chemotherapy in epithelial ovarian cancer stage I–III after complete surgical resection

✍ E.M. Grischke; R. Felderbaum; G.P. Breitbach; G. Bastert 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Combined Cisplatin and Carboplatin Chemo

Combined Cisplatin and Carboplatin Chemotherapy for Treatment of Advanced Epithelial Ovarian Cancer

✍ David M. Gershenson; Mitchell Morris; Thomas W. Burke; Charles Levenback; John J 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 402 KB

Cisplatin- based chemotherapy of epithel

Cisplatin- based chemotherapy of epithelial ovarian cancer

✍ Howard D. Homesley 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

The current International Federation of Gynecology and Obstetrics (FIGO) staging system, independent prognostic factors, and review of the Gynecologic Oncology Group (GOG) studies in epithelial ovarian carcinoma are presented. With this background, approaches using cisplatinbased regimens in ovarian